Search

Matthew R Hellmann

age ~45

from Tampa, FL

Also known as:
  • Matthew Hellmann
  • Matt Hellmann
  • Mark Hellmann

Matthew Hellmann Phones & Addresses

  • Tampa, FL
  • 119 Patterson Dr, Auburndale, FL 33823

Work

  • Position:
    Tampa and st petersburg, florida area

Industries

Financial Services

Resumes

Matthew Hellmann Photo 1

Tampa And St Petersburg, Florida Area

view source
Location:
1410 north West Shore Blvd, Tampa, FL 33629
Industry:
Financial Services
Work:

Tampa and St Petersburg, Florida Area

Medicine Doctors

Matthew Hellmann Photo 2

Matthew D. Hellmann

view source
Specialties:
Hematology/Oncology, Internal Medicine
Work:
Memorial Sloan Kettering Cancer Center
353 E 68 St, New York, NY 10065
(212)6392000 (phone), (212)9881079 (fax)
Education:
Medical School
Johns Hopkins University School of Medicine
Graduated: 2008
Conditions:
Melanoma
Acute Renal Failure
Anemia
Atrial Fibrillation and Atrial Flutter
Hemorrhagic stroke
Languages:
English
Description:
Dr. Hellmann graduated from the Johns Hopkins University School of Medicine in 2008. He works in New York, NY and specializes in Hematology/Oncology and Internal Medicine.

Googleplus

Matthew Hellmann Photo 3

Matthew Hellmann

Myspace

Matthew Hellmann Photo 4

Matthew Hellmann

view source
Locality:
Pennsylvania
Gender:
Male
Birthday:
1933

News

Immune Therapy Scores Big Win Against Lung Cancer In Study

Immune therapy scores big win against lung cancer in study

view source
  • The competitionDr. Matthew Hellmann of Memorial Sloan Kettering Cancer Center in New York led a study testing the Opdivo-Yervoy combo versus chemo in a slightly different group of newly diagnosed advanced lung cancer patients.
  • Date: Apr 17, 2018
  • Category: Health
  • Source: Google
Merck Drug Results Suggest It Will Extend Its Lead In Lung Cancer; Bristol-Myers Shares Drop

Merck drug results suggest it will extend its lead in lung cancer; Bristol-Myers shares drop

view source
  • "These practice-changing data establish the combination of nivolumab (Opdivo) plus ipilimumab (Yervoy) as a first-line treatment option for patients with high-TMB NSCLC," Dr. Matthew Hellmann, assistant attending at Memorial Sloan Kettering Cancer Center, said of the Bristol results.
  • Date: Apr 16, 2018
  • Category: Business
  • Source: Google
Immune Therapy Scores Big Win Against Lung Cancer In Study

Immune therapy scores big win against lung cancer in study

view source
  • Dr. Matthew Hellmann of Memorial Sloan Kettering Cancer Center in New York led a study testing the Opdivo-Yervoy combo versus chemo in a slightly different group of newly diagnosed advanced lung cancer patients.
  • Date: Apr 16, 2018
  • Category: Health
  • Source: Google

Facebook

Matthew Hellmann Photo 5

Matthew Hellmann

view source
Matthew Hellmann Photo 6

Matthew Hellmann

view source
Matthew Hellmann Photo 7

Matthew Hellmann

view source

Get Report for Matthew R Hellmann from Tampa, FL, age ~45
Control profile